OCTAPHARMA
- Country
- π«π·France
- Ownership
- -
- Established
- 1983-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://www.octapharma.com/
Safety and Efficacy Study of Three Different Dosages of NewGam in Patients With CIDP
- Conditions
- Interventions
- First Posted Date
- 2010-10-20
- Last Posted Date
- 2017-02-23
- Lead Sponsor
- Octapharma
- Target Recruit Count
- 2
- Registration Number
- NCT01225276
Efficacy and Safety Study of Human-cl rhFVIII in PTPs With Severe Hemophilia A
- First Posted Date
- 2010-05-18
- Last Posted Date
- 2017-09-11
- Lead Sponsor
- Octapharma
- Target Recruit Count
- 32
- Registration Number
- NCT01125813
- Locations
- π¦πΉ
Medizinische Universitaet Wien, Wien, Austria
π§π¬Haematological Hospital Joan Pavel, Sofia, Bulgaria
π©πͺWerlhof Institut fuer Haemostaseologie GmbH, Hannover, Niedersachsen, Germany
A Trial to Investigate the Relative Efficacy, Safety, and Tolerability of Octaplas LG Versus Octaplas SD
- Conditions
- Interventions
- First Posted Date
- 2010-02-05
- Last Posted Date
- 2014-05-20
- Lead Sponsor
- Octapharma
- Target Recruit Count
- 63
- Registration Number
- NCT01063595
- Locations
- π¦πΉ
Department of Clinical Pharmacology - Medical University Vienna, Vienna, Austria
A Study of NewGam, Human Immunoglobulin 10%, in Patients With Primary Immunodeficiency Diseases
- First Posted Date
- 2009-11-13
- Last Posted Date
- 2017-03-16
- Lead Sponsor
- Octapharma
- Target Recruit Count
- 51
- Registration Number
- NCT01012323
- Locations
- πΊπΈ
Sudir Gupta, MD, Irvine, California, United States
πΊπΈIsaac Melamed, MD, Centennial, Colorado, United States
πΊπΈWilliam Smits, MD, Fort Wayne, Indiana, United States
Clinical Study to Investigate the Pharmacokinetics, Efficacy, Safety and Immunogenicity of a Recombinant FVIII in Patients With Severe Hemophilia A
- Conditions
- Interventions
- First Posted Date
- 2009-10-02
- Last Posted Date
- 2019-10-08
- Lead Sponsor
- Octapharma
- Target Recruit Count
- 22
- Registration Number
- NCT00989196
- Locations
- πΊπΈ
UCLA Orthodpedic Hospital, Los Angeles, California, United States
πΊπΈUniversity of Medicine and Dentistry, New Brunswick, New Jersey, United States
π§π¬Prof. Lissitchkov, Sofia, Bulgaria
Study of Octagam (Intravenous Immunoglobulin [IVIG]) 10% on the Treatment of Mild to Moderate Alzheimer's Disease
- First Posted Date
- 2008-12-22
- Last Posted Date
- 2014-05-05
- Lead Sponsor
- Octapharma
- Target Recruit Count
- 58
- Registration Number
- NCT00812565
- Locations
- πΊπΈ
Octapharma USA, Hoboken, New Jersey, United States
Efficacy, Safety and Kinetics Study of Octagam 10% in Primary Immunodeficiency Diseases
- First Posted Date
- 2008-12-18
- Last Posted Date
- 2017-07-14
- Lead Sponsor
- Octapharma
- Target Recruit Count
- 5
- Registration Number
- NCT00811174
- Locations
- π¦πΉ
Contact Barbara Pyringer at Octapharma/ Vienna/ Austria for information, Vienna, Austria
Study of Octaplex (Human Prothrombin Complex Concentrate) and Fresh Frozen Plasma in Patients Under Vitamin K Therapy Antagonist Needing Urgent Surgery or Invasive Procedures
- Conditions
- Interventions
- First Posted Date
- 2008-02-18
- Last Posted Date
- 2023-01-31
- Lead Sponsor
- Octapharma
- Target Recruit Count
- 200
- Registration Number
- NCT00618098
- Locations
- πΊπΈ
Contact Octapharma for Facility details, Philadelphia, Pennsylvania, United States
Clinical Study to Evaluate the Efficacy and Safety of Octagam 10% in Idiopathic Thrombocytopenic Purpura in Adults
- First Posted Date
- 2007-01-24
- Last Posted Date
- 2014-08-01
- Lead Sponsor
- Octapharma
- Target Recruit Count
- 116
- Registration Number
- NCT00426270
- Locations
- π¦πΉ
Contact Octapharma for information, Vienna, Austria
Safety and Efficacy Study to Compare Uniplas With Cryosupernatant Plasma in Thrombotic Thrombocytopenic Purpura (TTP)
- Conditions
- Interventions
- First Posted Date
- 2006-12-15
- Last Posted Date
- 2017-06-21
- Lead Sponsor
- Octapharma
- Target Recruit Count
- 8
- Registration Number
- NCT00411801
- Locations
- πΊπΈ
Contact Octapharma for Facility Details, Centreville, Virginia, United States